6 research outputs found

    Efficiency of the MACD indicator applied o the CEZ stock

    Get PDF
    This paper deals with efficiency of the MACD indicator. The aim of the study is to find whether this indicator would be usable for creating a business strategy for active trading at a stock exchange. The research was carried out on the basis of day closing share prices of the company CEZ, traded on the Prague stock exchange, during the ten-year period from 2006 to 2016. The MACD indicator was calculated in three slightly modified methods. The first method was based on the crossing of MACD and signal line, the second method was similar but reliant on oscillation line. The last method was based on the crossing of MACD and oscillation line. All these methods were calculated in three time periods (short-term, medium-term and long-term). None of the MACD methods beat passive strategy “buy-andhold” in short-term period. However, for the medium-term and long-term periods, in four of six cases the MACD methods were better then the buy-and-hold strategy. Especially the third method shows very promising results. This study could be used as a building block for further research

    Efektivnost indikátoru MACD na akciích společnosti ČEZ

    No full text
    This paper deals with efficiency of the MACD indicator. The aim of the study is to find whether this indicator would be usable for creating a business strategy for active trading at a stock exchange. The research was carried out on the basis of day closing share prices of the company CEZ, traded on the Prague stock exchange, during the ten-year period from 2006 to 2016. The MACD indicator was calculated in three slightly modified methods. The first method was based on the crossing of MACD and signal line, the second method was similar but reliant on oscillation line. The last method was based on the crossing of MACD and oscillation line. All these methods were calculated in three time periods (short-term, medium-term and long-term). None of the MACD methods beat passive strategy “buy-and-hold” in short-term period. However, for the medium-term and long-term periods, in four of six cases the MACD methods were better then the buy-and-hold strategy. Especially the third method shows very promising results. This study could be used as a building block for further research

    Complicated and fatal Strongyloides infection in Canadians: risk factors, diagnosis and management

    No full text
    STRONGYLOIDIASIS, WHICH IS CAUSED by the nematode Strongyloides stercoralis, is a common and persistent infection, particularly in developing countries. In the setting of compromised cellular immunity, it can result in fulminant dissemination with case-fatality rates of over 70%. The majority of new Canadian immigrants come from countries where Strongyloides is highly endemic; therefore, the burden of Strongyloides may be underappreciated in Canada. Because early diagnosis and therapy can have a marked impact on disease outcome, screening for this infection should be considered mandatory for patients who have a history of travel or residence in a disease-endemic area and risk factors for disseminated disease (e.g., corticosteroid use and human T-lymphotropic virus type I infection)

    Carbapenem resistance in Canada

    No full text

    A Review of Amoebic Liver Abscess for Clinicians in a Nonendemic Setting

    No full text
    Amoebic liver abscess (ALA) is an uncommon but potentially life-threatening complication of infection with the protozoan parasite Entamoeba histolytica. E histolytica is widely distributed throughout the tropics and subtropics, causing up to 40 million infections annually. The parasite is transmitted via the fecal-oral route, and once it establishes itself in the colon, it has the propensity to invade the mucosa, leading to ulceration and colitis, and to disseminate to distant extraintestinal sites, the most common of which is the liver. The authors provide a topical review of ALA and summarize clinical data from a series of 29 patients with ALA presenting to seven hospitals in Toronto, Ontario, a nonendemic setting, over 30 years
    corecore